Intrinsic Value of S&P & Nasdaq Contact Us

Cogent Biosciences, Inc. COGT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$48.13
+31.9%

Stock Statistics — COGT

Cogent Biosciences, Inc. (COGT) has a market capitalization of $5.92B and trades at $36.49. The 52-week range is 3.72-43.73.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -14.3, Earnings Per Share (EPS) of $-2.55.

The stock has a beta of 0.47, operates in the Healthcare sector.

Trading Data
Current Price$36.49
52-Week Range3.72-43.73
Volume2.14M
Avg Volume (30D)2.15M
Market Cap$5.92B
Beta (1Y)0.47
Company
IPO Date2018-03-29
Employees205
CEOAndrew R. Robbins
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS19240Q2012
CUSIP19240Q201
Income (Latest Year)
Gross Profit$-4.62M
EBITDA$-328.74M
Operating Income$-333.36M
Net Income$-328.94M
EPS$-2.55
EPS Diluted$-2.55
Shares Outstanding$67.6M
Balance Sheet (Latest Year)
Total Assets$937.61M
Current Assets$910.36M
Cash & ST Investments$900.77M
Total Liabilities$301.24M
Total Debt$253.15M
Net Debt$-58.86M
Total Equity$636.37M
Debt / Equity0.40
Valuation Ratios
P/E Ratio-14.3
P/B Ratio9.31
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message